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SUMMARY
INTRODUCTION: Acute neurological illness often results in severe disability. Five-year life expectancy is around 40%; half the survivors 
become completely dependent on outside help. 
OBJECTIVE: Evaluate the symptoms of patients admitted to a Hospital ward with a diagnosis of stroke, subarachnoid hemorrhage or 
subdural hematoma, and analyze the role of an In-Hospital Palliative Care Support Team.
MATERIAL AND METHODS: Retrospective, observational study with a sample consisting of all patients admitted with acute neurological 
illness and with a guidance request made to the In-Hospital Palliative Care Support Team of a tertiary Hospital, over 5 years (2012-2016).
RESULTS: A total of 66 patients were evaluated, with an age median of 83 years old. Amongst them, there were 41 ischaemic strokes, 12 
intracranial bleedings, 12 subdural hematomas, and 5 subarachnoid hemorrhages. The median of delay between admission and guidance 
request was 14 days. On the first evaluation by the team, the GCS score median was 6/15 and the Palliative Performance Scale (PPS) 
median 10%. Dysphagia (96.8%) and bronchorrhea (48.4%) were the most prevalent symptoms. A total of 56 patients had a feeding tube 
(84.8%), 33 had vital sign monitoring (50.0%), 24 were hypocoagulated (36.3%), 25 lacked opioid or anti-muscarinic therapy for symptom 
control (37,9%); 6 patients retained orotracheal intubation, which was removed. In-hospital mortality was 72.7% (n=48).
DISCUSSION AND CONCLUSION: Patients were severely debilitated, in many cases futile interventions persisted, yet several were un-
der-medicated for symptom control. The delay between admission and collaboration request was high. Due to the high morbidity 
associated with acute neurological illness, palliative care should always be timely provided.
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ORIGINAL ARTICLE
INTRODUCTION
Acute neurological pathologies usually affect sev-
eral dimensions of the human being: their identity, 
cognition, and communication. Due to their natu-
ral severity, they often result in death, and the vast 
disability that derives from them often prevents the 
patient from making decisions regarding their own 
treatment1.
The majority of in-hospital deaths of hospital-
ized patients with cerebrovascular accidents (CVA) 
or traumatic brain injury happens after a clinical 
decision of limiting or suspending life support ther-
apies2-4. These decisions are, frequently, the result 
of complex and multidisciplinary discussions that 
involve setting a prognosis, a medical opinion, pref-
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erences of the patient and/or family, institutional 
regulations, and social values.
Therapeutic restrictions for patients of cute neu-
rological events are different from those adopted for 
chronic diseases since the continued maintenance of 
the treatment can often increase survival by months 
or years; however, it can also perpetuate a level of 
disability that might not be desired5,6. The uncertain-
ty that surrounds the circumstances of death, the dif-
ficulty in establishing a prognosis, and the concern 
in “prematurely” discontinuing active interventions 
with healing intent are the main factors responsible 
for the late introduction of palliative care for patients 
with acute neurological events7. In fact, 1-year mor-
tality is around 11% after lacunar stroke, 16% after 
partial anterior circulation infarct, 19% after posteri-
or infarct, 60% after total anterior circulation infarct, 
and 62% after intracerebral hemorrhage. SFive-year 
survival rates following an acute neurological event 
are around 40%, with half of the survivors facing dis-
ability and becoming entirely reliant on others8.
Most patients who survive an acute neurologi-
cal event and are discharged from hospital, develop 
persistent symptoms that require specialized care; 
the most frequent are pain (in up to 50% of patients 
within six months after the event), more specifical-
ly, central post-stroke pain and hemiplegic omalgia; 
fatigue (in over 50% of patients); fecal incontinence 
(50% during the acute stage; only 10% to 20% at the 
end of six months); vascular epilepsy with seizures 
(5% to 12%); psychological symptoms, such as depres-
sion (at least 33%), anxiety (20%) and delirium (10%-
48%, particularly in older patients and with more 
prolonged hospitalizations)9,10.
The purpose of this study is to assess the inter-
vention of an In-hospital Team for Palliative Care 
Support (IHTPCS) in the approach of patients with 
a CVA, SAH, or SDH, interaction with medical assis-
tant teams and evaluating the IHTPCS’s impact on 
symptom control.
MATERIAL AND METHODS
A retrospective observational study of all patients 
with a primary diagnosis of acute neurological event 
(CVA, ICH, SAH, or SDH) with a request for collab-
oration to the IHTPCS of a tertiary hospital over a 
period of five years (2012-2016) We collected infor-
mation concerning patients symptoms upon the 
IHTPCS’s assessment by means of a specific ques-
tionnaire designed and filled out by the this data was 
then digitally stored. In order to quantify pain, for 
patients aware an able to communicate, a numerical 
scale was applied; for those unable to communicate, 
the Pain Assessment in Advanced Dementia (Painad) 
scale was used. We extracted data relating to thera-
py in progress by means of computerized clinical re-
cords. Data was analyzed using IBM Statistics SPSS 
20®.
RESULTS
A total of 66 patients were included in the study, 
with a mean age of 83 years, 51.5% of whom were 
male (n=34). Most requests of collaboration to the 
EIHSCP came from the Neurology Service (65.2%, 
n=43), followed by the Traumatic Brain Injury Unit 
(TCE) (27.3%, n=18), and Internal Medicine (3.0%, 
n=2). Most events recorded were of ischemic etiol-
ogy (cerebral infarction), corresponding to 62.1% 
of cases (n=41), in comparison with hemorrhagic 
events (ICH, SAH, SDH), which correspond to the re-
mainder 37.9% (n=25) (Table 1). Within hemorrhagic 
events, the most frequently admitted etiologies were 
traumatic in 72.0% (n=18) of cases, uncontrolled hy-
pertension  in 12.0% (n=3), bleeding disorders in 8.0% 
(n=2), arteriovenous malformation in 1.5% (n=1), and 
severe thrombocytopenia in 1.5% (n=1).
The mean time between diagnosis and the re-
quest for collaboration with the EIHSCP was of 14 
days. The EIHSCP intervened within 48 hours after 
receiving each request.
TABLE 1: CHARACTERIZATION OF THE POPULATION
Total number of patients, n 66
Age, years
Mean (IQR 13.5) 83
Gender, n (%)
Female
Men
32 (49.5)
34 (51.5)
Referencing service, n (%)
Neurology
TCE Unit
Internal Medicine
Others
43 (65.2)
18 (27.3)
2 (3.0)
3 (4.5)
Type of event, n (%)
Ischemic
Hemorrhagic, traumatic
Hemorrhagic, non-traumatic
41 (62.1)
18 (27.3)
7 (10.6)
In-hospital mortality, n (%)
Ischemic
Hemorrhagic
29 (70.7)
19 (76.0)
IQR: Interquartile range; TCE: Traumatic Brain Injury
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In the first observation by the IHTPCS, the mean 
value for the Glasgow Coma Scale (GCS) was 6/15, 
and the mean value of the Palliative Performance 
Scale (PPS) was 10%.
Symptoms and signals most frequently iden-
tified during the first assessment by the IHTPCS 
were dysphagia (96.8%), aphasia or acute dysarthria 
(91.9%), bronchorrhea (48.4%), dyspnea (48.4%), 
constipation (46.8%), dry mouth (30.6%), and pain 
(30.3%) (Table 2).
At the moment of the first assessment, medical 
treatments in progress considered potentially futile 
included, nasogastric intubation (84.8%), urinary 
catheterization (66.7%), continuous cardiorespira-
tory monitoring (50.0%), and hypocoagulation in 
therapeutic or prophylactic dose (36.3%) (Table 3). 
Six patients had tracheal intubation (5 orotracheal 
and 1 tracheotomy): the orotracheal tube was later 
removed from all five patients. The mean number 
of antibiotic cycles per patient prior to the request 
for collaboration with the IHTPCS was two, with 
one case of nine complete antibiotic cycles prior to 
the initial assessment.
We found that 25 patients (37.9%) needed opi-
oid therapy for pain or dyspnea control, and 25 
patients needed antimuscarinic therapy to reduce 
bronchial secretions, which were not prescribed 
prior to the IHTPCS assessment and were initiated 
afterwards. In 25 cases pain control and antimus-
carinic therapy were already correctly prescribed 
by the assisting medical team upon the arrival of 
the EIHSCP.
In-hospital mortality was of 72.7% (n=48); for the 
group of patients with ischemic events, it was 70.7% 
(n=29); and for hemorrhagic events was 76.0% (n=19), 
with no significant changes in survival according to 
the etiology or location of the hemorrhage (Table 1). 
The average time between diagnosis death was of 24 
days.
None of the patients studied had advanced care 
directives.
DISCUSSION
The sample studied is, regarding age and gender 
distribution, similar to those documented in other 
studies on acute neurological events (especially in 
publications on ischemic stroke), as reported by Bur-
ton et al.11. The exceptions are studies regarding pal-
liative care that used patients admitted into Intensive 
Care Units (ICU), for which the mean age is consid-
erably lower, as is the case in the study conducted 
by Creutzfeldt et al.4 on the palliative needs in a Neu-
ro-ICU.
Up until 2014, there were no recommendations 
in the European or American guidelines concerning 
end of life care in patients with ischemic stroke, SAH, 
or traumatic brain injury1,12,13; it was only in 2014 that 
a document was published by the American Heart 
Association (AHA) and American Stroke Association 
(ASA)9 which contained guidelines for the palliative 
approach of patients with cerebral infarction, and in 
2015 they were also included in the American guide-
lines on spontaneous ICH14. In addition, most studies 
published on the palliative care needs of neurological 
patients rarely include different types of acute event; 
studies that most often include in the same sample 
cases of cerebral infarction, ICH, SAH, and SDH are 
those conducted in neurocritical care context4.
Authors who study palliative care needs in hem-
orrhagic neurological events report mortality rates 
above 50%, in situations of significant intracranial 
hemorrhage – similar to those found in middle cere-
bral artery (MCA) territory extensive infarction – and 
the need for palliative care, especially when decom-
pression surgery is not indicated or is ineffective15. In 
situations of subarachnoid hemorrhage, it is estimated 
TABLE 3: POTENTIALLY FUTILE MEASURES IDENTIFIED
Potentially futile measures, n (%)
Nasogastric intubation
Urinary catheterization
Cardiac monitoring
Hypocoagulation
Intravenous fluid therapy
Orotracheal tube (UTCE)
56 (84.8)
44 (66.7)
33 (50.0)
24 (36.3)
22 (33.3)
22 (33.3)
UTCE: Traumatic Brain Injury Unit
TABLE 2: FUNCTIONAL STATUS AND SYMPTOMS
GCS, mean (between 3-5 values) 6
PPS, mean (between 0%-100%) 10
Signals/Symptoms, n (%)
Changes in swallowing
Serious dysarthria or aphasia
Bronchorrhea
Dyspnea
Constipation
Dry mouth
Pain
Vascular epilepsy
Delirium
Anxiety/depression
64 (96.8)
60 (91.9)
32 (48.4)
32 (48.4)
31 (46.8)
21 (30.6)
20 (30.3)
19 (29.0)
13 (19.4)
9 (12.9)
GCS: Glasgow Coma Scale; PPS: Palliative Performance Scale
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that, similarly to intracranial hemorrhages, 50% of 
cases result in death, and one third in severe disabili-
ty15. In this present study, we found higher mortality 
rates in all groups (Ischemic and hemorrhagic stroke, 
SAH, and SDH), which might be explained by the in-
creased age and, consequently, decreased functional 
status of the patients included, in comparison with 
other publication, as previously mentioned.
We highlight the mean time between diagnosis 
and the request for collaboration to the IHTPCS, 
of over 20 days, associated with the high degree of 
frailty of these patients at the moment of the first 
assessment by the team – particularly evident when 
compared to other studies with a similar scope, like 
the one by Mazzocato et al.16, in which only 26% of 
patients were in stupor or coma. Even though it is 
possible for the neurological status to deteriorate 
during hospital stay – it is impossible to evaluate this 
progression without a PPS score at the moment of 
admission, and in some cases even the initial GCS 
was omitted from the records –, it would be bene-
ficial to signal these cases in a more timely fashion, 
regardless of any healing goals established by the as-
sistant team, so that symptomatic control can be op-
timized in the early stages of treatment. This model 
of early signaling is already followed by several units 
and wards, as described in the studies published by 
Creutzfeldt et al.4 e Burton et al.11, among others.
There are many possible symptomatic manifes-
tations with patients of acute neurological events, 
with considerably variable intensity. In the AHA/
ASA guidelines on this topic12, the management of 
several symptoms is described – pain, fatigue, fecal 
incontinence, vascular epilepsy, sexual dysfunc-
tion, sleep apnea, and psychological symptoms –, 
whose incidence in this sample, as in the popula-
tions described in other studies16, is less evident in 
comparison to other complaints. We highlight, for 
example, the presence of dyspnea, dysphagia, con-
stipation, and dry mouth, all of which whose fre-
quency is considerable and which cause significant 
discomfort for the patients.
In this context, the evident cognitive deteriora-
tion of most patients becomes even more relevant, 
as does the high incidence of aphasia in conscious 
patients –restrictions which limit the expression of 
most symptoms, making it harder to identify and 
manage them in due time by the clinician. In these 
situations, a correct evaluation of suggestive signs of 
discomfort is of great importance, among which are 
bronchorrhea,  polypnea, or muscle contractions in-
dicatives of underlying pain.
Identification and suspension of futile therapeu-
tic measures is as important as proper symptomatic 
control. In comparison with other published studies, 
we found that there is still a high prevalence of in-
terventions whose benefits in terminal neurological 
patients are questionable. One example of that is the 
number of patients with NG tubes at the time of the 
first assessment – present in 84.8% of patients – in 
comparison with data from the study by Blacquiere 
et al.17, according to which 56.4% (n=53) of their sam-
ple was never subjected to NG tubes, and 40.4% had 
it removed. The monitoring of vital signs, continuous 
or regular, still remains one of the futile measures 
most often found by IHTPCS, as well as the use of 
non-palliative medication in terminal patients17. 
Similarly to what is found in other publications16, 
the intervention by IHTPCS was necessary for optimi-
zation of symptomatic medical therapy in one-third of 
cases of uncontrolled pain/dyspnea and bronchorrhea.
The primary limitation of this study is the ret-
rospective nature of data analysis. The scarcity of 
details in medical and nursing records, especially 
regarding patients’ evolution during treatment, lim-
its the possibilities for interpretation of some data. 
In the same way, the advanced disability of most pa-
tients often compromised the process of correctly 
assessing their palliative needs, as was the case with 
the absence of advanced care directives or records 
stating the opinions of close care providers.  
CONCLUSIONS
Patients with major acute neurological events 
are often dependent on others, have multiple symp-
toms, are incapable of expressing their symptoms 
and desires and are frequently referred to Palliative 
Care teams too late in the course of their illness. It 
is the responsibility of health professionals to look 
after the best interests of these patient, providing 
timely symptomatic control and avoiding therapeu-
tic obstinacy which might worsen the discomfort or 
anguish, with no expectation of clinical benefit. The 
development of new tools aimed for this type of sit-
uation, which allow for easier identification of these 
patients’ needs, will likely bring significant benefits, 
as will increased awareness of clinicians about im-
plementation of palliative measures and when to re-
fer these cases to specialized teams.
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RESUMO:
INTRODUÇÃO: Eventos neurológicos agudos resultam frequentemente em incapacidade grave que impede o doente de participar ativa-
mente nas decisões do seu próprio tratamento. A sobrevida a cinco anos ronda os 40%; metade dos sobreviventes fica dependente de 
terceiros. Objetivo: Avaliar a sintomatologia de doentes internados com acidente vascular cerebral (AVC), hemorragia subarcnoideia 
(HSA) ou subdural (HSD) e analisar a intervenção de uma Equipe Intra-Hospitalar de Suporte em Cuidados Paliativos (EIHSCP).
MATERIAL E MÉTODOS: Estudo retrospetivo observacional dos doentes com diagnóstico principal de evento neurológico agudo com 
pedido de colaboração à EIHSCP, num hospital terciário, durante cinco anos (2012-2016).
RESULTADOS: Avaliados 66 doentes, com média de idade de 83 anos. Destacam-se 41 AVC isquêmicos, 12 hemorrágicos, 12 HSD e 5 
HSA. A média da demora entre internamento e pedido de colaboração à EIHSCP foi de 14 dias. Na primeira observação, a média na 
escala de coma de Glasgow foi de 6/15 e na Palliative Performance Scale (PPS) foi de 10%. Disfagia (96,8%) e broncorreia (48,4%) 
foram os sintomas mais frequentes. A maioria dos doentes (56/66) mantinha sonda nasogástrica (84,8%); 33 encontravam-se em 
monitorização cardiorrespiratória (50,0%); 24 estavam sob hipocoagulação (36,3%); 25 necessitavam de opioide e antimuscarínico 
que não estavam prescritos (37,9%); seis tinham tubo orotraqueal, que foi retirado. A mortalidade intra-hospitalar foi de 72,7% (n=48).
DISCUSSÃO E CONCLUSÃO: Destaca-se o estado debilitado dos doentes; em muitos casos, intervenções fúteis persistiam, mas várias 
foram submedicadas para o controle dos sintomas. Verificou-se um tempo de espera elevado até o pedido de colaboração. Pela eleva-
da morbilidade associada a esses eventos, cuidados paliativos diferenciados deveriam ser oferecidos no tempo adequado.
PALAVRAS-CHAVE: Cuidados paliativos. Acidente vascular cerebral. Transtornos cerebrovasculares.
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